Literature DB >> 11106272

Genetics of brain tumors.

W A Weiss1.   

Abstract

Brain tumors are among the most common forms of cancer in children and account for most cancer-related deaths in this age group. The incidence of brain tumors appears to be increasing in children, while therapeutic advances have been modest. Few genetic studies exist on pediatric brain tumors, in part because tissue from low-grade and brain stem tumors is not readily available, and also because individual centers have relatively few cases. Genetic changes in infiltrating astrocytomas involve genes in the p53 and RB pathways, and show alterations that are similar to infiltrating astrocytomas in adults. The PTC gene is mutated in a subgroup of medulloblastomas, and may lead to increased proliferation in granule cells that normally express this receptor. Further studies are needed to identify genetic alterations in pilocytic and low-grade astrocytomas, which account for 40% of brain tumors in children.

Entities:  

Mesh:

Year:  2000        PMID: 11106272     DOI: 10.1097/00008480-200012000-00005

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  7 in total

1.  CD133+ cells from medulloblastoma and PNET cell lines are more resistant to cyclopamine inhibition of the sonic hedgehog signaling pathway than CD133- cells.

Authors:  Mónica Enguita-Germán; Paula Schiapparelli; Juan A Rey; Javier S Castresana
Journal:  Tumour Biol       Date:  2010-05-18

Review 2.  Maternal embryonic leucine zipper kinase: key kinase for stem cell phenotype in glioma and other cancers.

Authors:  Ranjit Ganguly; Christopher S Hong; Luke G F Smith; Harley I Kornblum; Ichiro Nakano
Journal:  Mol Cancer Ther       Date:  2014-05-02       Impact factor: 6.261

Review 3.  Pharmacotherapeutic management of pediatric gliomas : current and upcoming strategies.

Authors:  Trent R Hummel; Lionel M Chow; Maryam Fouladi; David Franz
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

4.  Estrogen receptor beta (ERbeta) is expressed in brain astrocytic tumors and declines with dedifferentiation of the neoplasm.

Authors:  Anna Batistatou; Dimitrios Stefanou; Anna Goussia; Evdokia Arkoumani; Athanasios G Papavassiliou; Niki J Agnantis
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

5.  Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.

Authors:  Chunyu Gu; Yeshavanth K Banasavadi-Siddegowda; Kaushal Joshi; Yuko Nakamura; Habibe Kurt; Snehalata Gupta; Ichiro Nakano
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

6.  Fatty acid synthase: a novel target for antiglioma therapy.

Authors:  W Zhao; S Kridel; A Thorburn; M Kooshki; J Little; S Hebbar; M Robbins
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

Review 7.  Brain Tumor Characterization Using Radiogenomics in Artificial Intelligence Framework.

Authors:  Biswajit Jena; Sanjay Saxena; Gopal Krishna Nayak; Antonella Balestrieri; Neha Gupta; Narinder N Khanna; John R Laird; Manudeep K Kalra; Mostafa M Fouda; Luca Saba; Jasjit S Suri
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.